Single-cell profiling of acral melanoma infiltrating lymphocytes reveals a suppressive tumor microenvironment | Science Translational Medicine science.org/doi/10.1126/sc…

Discovery of a new biomarker (RNAPII) in cancer that denotes aggressiveness, increased risk of recurrence, shown in breast cancer and meningioma (<-Figure) Science Magazine science.org/doi/10.1126/sc…

The AACR is deeply concerned that the Administration’s recent actions are threatening NIH and its mission to accelerate progress for patients with cancer and other diseases that afflict millions of Americans. We urge Congress to restore stability to NIH: brnw.ch/21wQMO3

Our report has lots of data but is also in plain English. We back everything up with references. Feel free to run it through AI to pressure test. We wrote it for our friends and families. We hope it helps you and those you may know. Here's the link. rapport.bio/all-stories/a-…

Devastating to hear of a child's death from measles—a completely preventable disease. Even more concerning is public health officials downplaying the outbreak. attached is an important article on the lifesaving impact of measles vaccines. #FollowTheData academic.oup.com/jid/article/22…

🧵 "Why I ignore Nature Methods papers when choosing bioinformatics tools (sometimes) - a practical guide to tool selection..." (1/10)

Integrated computational analysis identifies therapeutic targets with dual action in cancer cells and T cells Immunity cell.com/immunity/fullt…

I am very proud to be part of the amazing team of researchers, scientists and clinicians who are all co-authors of the important research publication just released in Nature Medicine. The paper documents changes in my brain tumour & blood before and after I received neoadjuvant

Review Trends in Immunology Reina Mebius Lymph node fibroblast-produced extracellular matrix shapes immune function cell.com/trends/immunol…

🚨 a must listen - Leading French scientists denounce the U.S. restrictions on research, comparing them to the suppression of science under Mao’s regime in the 1930s. France Inter radiofrance.fr/franceinter/po…

📢 CDMRP to be cut 57%. The vote on this bill could be as early as Tuesday. Melanoma Research Foundation has a link to make it easy to contact your district representative: lnkd.in/g-p-3tRV

A very well deserved honor! I would like to highlight that these individuals have made foundational discoveries in cancer research, supported through CDMRP including Drs. Nina Bhardwaj and Garrett Brodeur (PRCRP) and David Fisher (MRP Melanoma Academy) ‼️melanoma.quorum.us/campaign/CDMRP/

Dear Trainees, bookmark this👇 Dr. Marco Ruella Society for Immunotherapy of Cancer teaching us how to give a good talk, by purposefully giving a *bad* talk! 👏😉 - Lighter the better - Less is more - Consistent font - Large font size (>=18) - Careful with animations: friends sometimes (to help introduce

Today marks the beginning of OpenRxiv, which replaces bioRxiv and medRxiv, the world's largest preprint platform for life and medical science openrxiv

Excellent article that highlights the contribution of NIH grant funding to fueling economic activity. An important read especially for non- scientist to understand how disruptive NIH cuts are both to medicine and to the economy.

Microplastics cross the murine intestine and induce inflammatory cell death after phagocytosis by human monocytes and neutrophils doi.org/10.1101/2025.0…

PhD students: Remember to apply for the Google PhD fellowship. It will make your PhD super smooth. Application opens on 10th April 2025 Deadline: 15th May 2025

In a recent study on Cancer Cell, Platten lab (DKFZ) highlights the pivotal role of MHCII-restricted antigen presentation by tumor-infiltrating blood-borne myeloid cells (BBMs) in maintaining CD8+ T cell functionality within brain tumors. MHCII-restricted antigen presentation

Published in Immunity, Peter Fecci lab (Duke Neurosurgery), Jan 2025. Tumor-associated macrophages (TAMs), not tumor cells, are primary mediators of progression from progenitor-exhausted to terminally-exhausted T cell state in GBM. TAM-T cell interaction are typically prolonged

NSF GRFP #'s cut in half year-on-year 2022: 2193 awards, 1,377 Honorable Mentions 2023: 2555 awards, 801 Honorable Mentions 2024: 2026 awards, 1718 Honorable Mentions 2025: 1000 awards, 3008 Honorable Mentions The gutting continues apace. research.gov/grfp/AwardeeLi…